Clinical heterogeneity of α-synuclein gene duplication in Parkinson's disease

Annals of Neurology

Volumn 59, Issue 2, 2006, Pages 298-309

  Nishioka, Kenya ^a   Hayashi, Shin ^b   Farrer, Matthew J ^c   Singleton, Andrew B ^d   Yoshino, Hiroyo ^a   Imai, Hisamasa ^e   Kitami, Toshiaki ^a   Sato, Kenichi ^a   Kuroda, Ryu ^f   Tomiyama, Hiroyuki ^a,f   Mizoguchi, Koichi ^f   Murata, Miho ^g,h   Toda, Tatsushi ^h,i   Imoto, Issei ^b   Inazawa, Johji ^b   Mizuno, Yoshikuni ^a   Hattori, Nobutaka ^a,h  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c MAYO GRADUATE SCHOOL   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e TOKYO RINKAI HOSPITAL   (Japan)

^f SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

^g NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^h JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

ⁱ OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DEMENTIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DUPLICATION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC HETEROGENEITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; PARKINSON DISEASE; PARKINSONISM; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL;

AGED; ALPHA-SYNUCLEIN; BRAIN MAPPING; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; FUNCTIONAL LATERALITY; GENE DOSAGE; GENE DUPLICATION; GENETIC HETEROGENEITY; HAPLOTYPES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSON DISEASE; PEDIGREE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 32044453611     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20753     Document Type: Article

References (36)

1. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;21:256-259.
2. Gasser T, Muller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998;18:262-265.
3. Hicks AA, Petursson H, Jonsson T, et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol 2002;52:549-555.
4. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-452.
5. Kitada T, Asakawa S, Hattori N, et al., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-608.
6. Le WD, Xu P, Jankovic J, et al. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 2003;33:85-89.
7. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
8. Pankratz N, Nichols WC, Uniacke SK, et al. Significant linkage of Parkinson disease to chromosome 2q36-37. Am J Hum Genet 2003;72:1053-1057.
9. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
10. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004;21:1158-1160.
11. Singleton AB, Farrer M, Johnson J, et al. α-Synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.
12. Chartier-Harlin MC, Kachergus J, Roumier C, et al. α-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004;364:1167-1169.
13. Ibanez P, Bonnet AM, Debarges B, et al., Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 2004;25:1169-1171.
14. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.
15. Kruger R, Kuhn W, Leenders KL, et al. Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers. Neurology 2001;22:1355-1362.
16. Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164-173.
17. Spillantini MG, Schmidt ML, Lee VM, et al. α-Synuclein in Lewy bodies. Nature 1997;28:839-840.
18. Vaughan J, Durr A, Tassin J, et al. The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic susceptibility in Parkinson's Disease. Ann Neurol 1998;44:270-273.
19. Farrer M, Kachergus J, Forno L, et al. Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications. Ann Neurol 2004;55:174-179.
20. Muenter MD, Forno LS, Hornykiewicz O, et al. Hereditary form of parkinsonism-dementia. Ann Neurol 1998;43:768-781
21. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
22. Johnson J, Hague SM, Hanson M, et al. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 2004;63:554-556.
23. Ariyama T, Inazawa J, Uemura Y, et al. Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia. Cancer Genet Cytogenet 1995;81:2023.
24. Saito-Ohara F, Fukuda Y, Ito M, et al. The Xq22 inversion breakpoint interrupted a novel ras-like GTPase gene in a patient with Duchenne muscular dystrophy and profound mental retardation. Am J Hum Genet 2002;71:637-645.
25. Inazawa J, Inoue J, Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 2004;95:559-563.
26. Sonoda I, Imoto I, Inoue J, et al. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res 2004;64:3741-3747.
27. Takada H, Imoto I, Tsuda H, et al. Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Sci 2005;96:100-110.
28. Gispert S, Trenkwalder C, Mota-Vieira L, et al. Failure to find alpha-synuclein gene dosage changes in 190 patients with familial Parkinson disease. Arch Neurol 2005;62:96-98.
29. Lockhart PJ, Kachergus J, Lincoln S, et al. Multiplication of the alpha-synuclein gene is not a common disease mechanism in Lewy body disease. J Mol Neurosci 2004;24:337-342.
30. Hayward CP, Hassell JA, Denomme GA, et al. The cDNA sequence of human endothelial cell multimerin. A unique protein with RGDS, coiled-coil, and epidermal growth factor-like domains and a carboxyl terminus similar to the globular domain of complement C1q and collagens type VIII and X. J Biol Chem 1995;270:18246-18251.
31. Singleton A, Gwinn-Hardy K, Sharabi Y, et al. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain 2004;127:768-772.
32. Nagayama H, Hamamoto M, Ueda M, et al. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2005;76:249-251.
33. 123I] metaiodobenzylguanidine myocardial scintigraphy differentiates corticobasal degeneration from Parkinson's disease. Intern Med 2003;42:127-128.
34. 123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report. Mov Disord 2005;20:634-636.
35. Mueller JC, Fuchs J, Hofer A, et al. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann Neurol 2005;57:535-541.
36. Pals P, Lincoln S, Manning J, et al. α-Synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol 2004;56:591-595.